Shebli Atrash, MD
Articles
Bispecific Antibody Combinations In Relapsed Refractory Multiple Myeloma: TRIMM-2 Study
Ajai Chari, MD;Thomas G. Martin, MD;Jens Hillengass, MD, PhD ;Beth Faiman PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO ;Louis Williams, MD;Shebli Atrash, MD ;Donna Catamero, ANP-BC, OCN, CCRC;Cesar Rodriguez Valdes, MD ;Shambavi Richard, MD
October 30th 2024Panelists discuss how the TRIMM-2 study explores the potential of combining bispecific antibodies to enhance treatment efficacy in patients with relapsed/refractory multiple myeloma, potentially offering a novel therapeutic strategy for this difficult-to-treat condition.
Ajai Chari, MD;Thomas G. Martin, MD;Jens Hillengass, MD, PhD ;Beth Faiman PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO ;Louis Williams, MD;Shebli Atrash, MD ;Donna Catamero, ANP-BC, OCN, CCRC;Cesar Rodriguez Valdes, MD ;Shambavi Richard, MD
October 30th 2024Panelists discuss how Talquetamab, a novel GPRC5DxCD3 bispecific antibody, shows promising results in treating relapsed/refractory multiple myeloma based on the MonumenTAL-1 trial data, potentially offering a new therapeutic option for this challenging patient population.
Latest Updated Articles
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: August 26th 2011 | Updated: November 1st 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: May 1st 2015 | Updated: November 1st 2024
Neutropenia and Abdominal Pain in a 30-Year-Old Patient
Published: October 22nd 2024 | Updated: November 1st 2024
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors
